ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 103 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,896 | – | 11,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,877,305 | $10,025,000 | 5.86% |
| Prosight Management, LP | 1,210,800 | $6,466,000 | 3.46% |
| Perceptive Advisors | 11,350,085 | $60,609,000 | 1.76% |
| JOHNSON & JOHNSON | 394,834 | $2,108,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $3,738,000 | 0.46% |
| APOGEM CAPITAL LLC | 85,091 | $454,000 | 0.45% |
| 683 Capital Management, LLC | 700,000 | $3,738,000 | 0.29% |
| EAM Investors, LLC | 233,638 | $1,248,000 | 0.27% |
| Verition Fund Management LLC | 4,804,478 | $12,840,828 | 0.14% |
| WOODSTOCK CORP | 129,179 | $690,000 | 0.10% |